“Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, Apr. 2026, https://doi.org/10.4084/MJHID.2026.044.